JFA
CNCE

JNBA Financial Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

JNBA Financial Advisors’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-75
Closed -$1K – 559
2016
Q1 		$1K Buy
+75
New +$1.08K ﹤0.01% 525

Other funds holding CNCE

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

JNBA Financial Advisors's CNCE Position: Q2 2016 in Review

JNBA Financial Advisors sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2016, closing a stake of 75 shares — an estimated $1K sold.

JNBA Financial Advisors first reported a position in CNCE in Q1 2016 and held it in 1 quarter. The position peaked at $1K in Q1 2016. 97 funds tracked by Wall St. Rank hold CNCE as of Q2 2016.

  • JNBA Financial Advisors reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • JNBA Financial Advisors sold 75 Concert Pharmaceuticals, Inc. shares in Q2 2016, an estimated $1K.
  • JNBA Financial Advisors first reported a position in Concert Pharmaceuticals, Inc. in Q1 2016 and held it in 1 quarter.
  • JNBA Financial Advisors's Concert Pharmaceuticals, Inc. position peaked at $1K in Q1 2016.
  • 97 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2016.

Based on JNBA Financial Advisors's 13F filing for Q2 2016, filed 22 Jul 2016.